PHA vs Microplastics: Why Biodegradable Polymers Reduce Plastic Pollution

August 2, 2026

A sustainability officer at a European hospital group recently asked us a direct question: “If we switch our waste bags and underpads from conventional polyethylene to a bioplastic, are we actually reducing microplastic pollution — or just changing the label?” It deserves an evidence-based answer. This guide explains what microplastics are, why conventional polymers keep generating them, and how PHA (polyhydroxyalkanoates) breaks the cycle.

Compostable waste bags for eco-conscious healthcare

What microplastics are and why they matter

Microplastics are plastic fragments smaller than 5 millimetres, created when larger plastic items wear, fragment, or degrade. They are now found in marine sediments, in the food chain, in drinking water, and in human tissue. Healthcare is a significant contributor: single-use packaging, waste bags, gloves, and underpads are among the highest-volume plastic items in clinical settings.

Once in the environment, microplastics persist for centuries. Research on global plastic production (Geyer et al., 2017, Science Advances, PubMed Central) estimated that by 2017 roughly 8.3 billion metric tonnes of virgin plastic had been produced, with most plastic waste accumulating in landfills or the environment.

Why conventional plastics fragment instead of degrading

Polyethylene (PE) and polypropylene (PP) — the polymers behind most waste bags, underpads, and sterile packaging — are engineered to resist breakdown. That durability is an asset at the point of use and a liability afterwards. In the open environment, UV light, wave action, and abrasion break them into ever-smaller fragments: they do not biodegrade on human timescales, they simply become microplastics.

How PHA breaks the cycle

PHA is a family of biobased polyesters produced by microorganisms as intracellular energy storage. The same microorganisms found in soil, freshwater, and marine environments can metabolise it. Under ambient conditions, PHA degrades into carbon dioxide, water, and biomass — the natural end products of biological breakdown — rather than persistent fragments. Peer-reviewed studies in PubMed Central and MDPI’s Polymers journal have measured meaningful mass loss of PHA in seawater and marine sediment within months to roughly two years.

Because degradation is driven by microbial activity rather than heat or industrial infrastructure, PHA behaves differently from many other bioplastics.

PHA vs PLA vs conventional plastic: pollution profile

Plastic type	Degradation in the environment	Microplastic risk
PE / PP (conventional)	None on human timescales; fragments instead	High
PLA (biobased)	Only under industrial composting conditions	Moderate — persists in soil and marine environments
PHA	Biodegradable in soil, freshwater, and marine environments	Low

PLA is biobased but not a standalone solution: it requires industrial composting at elevated temperatures, and in soil or seawater it behaves much like conventional plastic. PHA’s broader biodegradability profile is why it is increasingly specified for single-use medical items.

Eco-friendly medical underpad

‘Biodegradable’ claims need certification

On its own, “biodegradable” is close to meaningless — almost any material will eventually break down. Credible claims rest on recognised standards: EN 13432 and ASTM D6400 for industrial composting, and TÜV Austria’s OK compost HOME for home composting. European Bioplastics maintains guidance on these standards and stresses that biodegradability is tied to specific environments and timescales. Buyers should ask which standard applies, in which environment, within what timeframe — and request the test reports.

Honest limits: PHA is not a licence to litter

PHA still needs to reach an environment where degrading microorganisms are active. In a dry, oxygen-limited landfill, degradation can slow considerably. PHA is not a licence to litter, and it does not replace reduction and reuse. It also costs more than conventional polymers today, which is why it appears first in high-value single-use clinical applications. Material choice is one part of a waste hierarchy — prevention, reduction, reuse, and correct disposal still come first.

What eco-conscious healthcare buyers should look for

Procurement teams comparing suppliers should verify four things: certified compostability against a named standard; clear end-of-life labelling so staff know the disposal route; third-party biodegradation test data for the product and environment; and transparency about polymer composition. For a deeper look at how degradation claims differ by environment, see our guide on PHA biodegradation across home compost, industrial compost, and marine settings, or start with the basics of what PHA is. If your team is weighing disposal terminology, our comparison of biodegradable vs compostable vs recyclable medical waste terms clarifies the vocabulary used in tenders.

So, back to the sustainability officer’s question: yes, switching from PE to PHA can meaningfully reduce microplastic pollution — provided the material is certified, the disposal route is understood, and waste discipline is maintained. No polymer is a substitute for good waste management. Among materials available to healthcare today, PHA is one of the few whose end-of-life chemistry aligns with the natural carbon cycle rather than centuries of fragmentation. That is a difference worth specifying.

Facilities shifting toward greener purchasing often start with high-volume disposables. CliniEco offers PLA biodegradable underpads and PLA bed sheets as a practical, certified starting point for Canadian clinics and long-term care homes.